임상약리학과

유형균

전문분야
임상약리학
진료일정
교수 경력
  • 차의과학대학교
진료 경력
  • 서울대학교병원 임상약리학과 연구임상강사
  • 분당차병원 임상약리학과 임상강사
  • 분당차병원 임상약리학과 임상연구조교수
  • 분당차병원 임상약리학과 임상조교수
  • 現 차의과학대학교 분당차병원 임상약리학과 조교수
학력사항
  • 차의과학대학교 의학전문대학원 졸업
  • 서울대학교 의과대학 협동과정 임상약리학전공 박사
학회/연구/Postdoctorial Fellowship/수상경력
  • 대한임상약리학회 정회원
  • 미국임상약리학회 정회원
  • 일본임상약리학회 정회원
  1. Assessing the Clinical Efficacy of Therapeutic Drug Monitoring for Risperidone and Paliperidone in Patients with Schizophrenia: Insights from a Clinical Data Warehouse, Pharmaceuticals, 2024-07, (국외)SCI
  2. Assessing the Clinical Efficacy of Therapeutic Drug Monitoring for Risperidone and Paliperidone in Patients with Schizophrenia: Insights from a Clinical Data Warehouse, Pharmaceuticals, 2024-07, (국외)SCI
  3. Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors, Frontiers in Medicine, 2024-02, (국외)SCI
  4. Drug?Drug Interactions between Tamsulosin and Mirabegron in Healthy Individuals Do Not Affect Pharmacokinetics and Hemodynamic Parameters Significantly, Pharmaceuticals, 2023-10, (국외)SCI
  5. A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State, Pharmaceuticals, 2023-08, (국외)SCI
  6. Pharmacokinetics and Food EffectBetween a 100-mg Sustained-ReleaseTablet and a 50-mg Immediate-ReleaseTablet of Vildagliptin in HealthySubjects, Clinical Pharmacology in Drug Development, 2023-07, (국외)SCI
  7. Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation, Translational Clinical Pharmacology, 2023-03, (국외)기타
  8. Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration, Pharmaceuticals, 2023-01, (국외)SCI
  9. The Safety of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World Data, Vaccines, 2022-02, (국외)SCI
  10. Tissue pharmacokinetics of DHP107, a novel lipid-based oral formulation of paclitaxel, in mice and patients by positron emission tomography, Clinical and translational science, 2021-02, (국외)SCIE
  11. Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia, NPJ Schizophrenia, 2020-11, (국외)SCIE
  12. Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects, Translational & clinical pharmacology, 2020-09, (국내)SCOPUS
  13. Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor-Mediated Recycling of HL2351, a Novel Hybrid Fc-Fused Interleukin-1 Receptor Antagonist, to Optimize Dosage Regimen, CPT: pharmacometrics & systems pharmacology, 2020-08, (국외)SCIE
  14. An investigation of the metabolism and excretion of KD101 and its inter-individual differences: a microtracing mass balance study in humans, Clinical and translational science, 2020-06, (국외)SCI
  15. Exposure-response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients , Pharmaceutics, 2020-04, (국외)SCIE
  16. Increasing Prevalence and Mortality of Asthma With Age in Korea, 2002?2015: A Nationwide, Population-Based Study, allergy, asthma and immunology research, 2020-01, (국외)SCIE
  17. Human ADME using Wavelength Scanning Cavity Ring-Down Spectroscopy (WS-CRDS) after a low radioactivity dose, Bioanalysis, 2019-12, (국외)SCIE
  18. Evaluation of the Effect of CYP2D6 Genotypes on Tramadol and O-Desmethyltramadol Pharmacokinetic Profiles in a Korean Population Using Physiologically-Based Pharmacokinetic Modeling, Pharmaceutics, 2019-11, (국외)SCIE
  19. Trabecular Bone Score Is More Sensitive to Asthma Severity and Glucocorticoid Treatment Than Bone Mineral Density in Asthmatics, allergy, asthma and immunology research, 2019-01, (국외)SCI
더보기